new glp 1 drugs in development What is the pipeline for future medications for obesity? GLP-1 Market Industry Trends and
Description
If compounded GLP-1 drugs become unavailable, employers will face increased pressure to provide coverage for GLP-1 medications for their members who are obese overweight with a metabolic complication
Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, et al
The development of oral semaglutide (Ozempic, Rybelsus) can also drive the market growth
This means even in states like Pennsylvania that eliminated adult obesity GLP-1 coverage, children under 21 may still qualify
Slowly pull back the plunger to draw your prescribed amount
